// App-Quantinova.ai

161 : Clinical and Laboratory Characteristics of Persistently Antiphospholipid Antibody Positive Patients: Retrospective Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registryâ€)

Researchers

Presenter

  • Diane F. Zisa

Principal Investigators

  • Vittorio Pengo

  • Maria Tektonidou

  • Amaia Ugarte

  • Maria Gerosa

  • Lanlan Ji

  • Maria Efthymiou

  • Guilherme Ramires de Jesus

  • David Branch

  • Cecilia Nalli

  • Savino Sciascia

  • H. Michael Belmont

  • Paul R. Fortin

  • Michelle Petri

  • Esther Rodriguez-Almaraz

  • Rosana Quintana

  • Jason S Knight

  • Rohan Willis

  • Tatsuya Atsumi

  • Maria Laura Bertolaccini

  • Doruk Erkan

  • Medha Barbhaiya

Medical Centers

  • Division of Rheumatology, Hospital for Special Surgery, New York, NY

  • Department of Medicine, Weill Cornell Medicine, New York, NY, USA., New York, NY

  • Rheumatology, Hospital das Clinicas, Faculdade de Medicina, University of Sao Paulo, Sao Paulo, Brazil

  • Azienda Ospedaliera of Padova, University of Padova, Padova, Italy

  • Rheumatology Unit, st Dept of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, Athens University Medical School, Athens, Greece

  • Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain

  • Istituto Ortopedico Gaetano Pini, University of Milan, Milan, Italy

  • Department of Rheumatology and Immunology, Peking University Third hospital, Bei jing, China

  • Haemostasis Research Unit, Department of Haematology, University College London, London, United Kingdom

  • Internal Medicine, Univ Estado Do Rio De Janeiro, Rio de Janeiro, Brazil

  • Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, UT

  • Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy

  • Center of Research of Immunopathology and Rare Diseases- Coordinating Center of Piemonte and Valle d’Aosta Network for Rare Diseases, Department of Clinical and Biological Sciences, University of Turin, Italy, Center of Research of Immunopathology and Rare Diseases- Coordinating Center of Piemonte and Valle d’Aosta Network for Rare Diseases, Department of Clinical and Biological Sciences, University of Turin, Italy, Torino, Italy

  • Medicine, NYU Langone Health, New York, NY

  • CHU de Quebec - Universite Laval, Quebec City, QC, Canada

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Hospital Universitario Doce de Octubre, Madrid, Spain

  • Argentina, GLADEL, Rosario, Argentina

  • University of Michigan, Ann Arbor, MI

  • 301 University Blvd, Antiphospholipid Standardization Laboratory, University of Texas Medical Branch, Galveston, TX, USA, Galveston, TX

  • Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan

  • Kings College London, London, United Kingdom

  • Rheumatology, Hospital for Special Surgery- Weill Cornell Medicine, New York, NY

  • Division of Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY

Locations

  • United States

  • Brazil

  • Italy

  • Greece

  • Spain

  • China

  • United Kingdom

  • Canada

  • Argentina

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Cluster of differentiation 79A

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved